Want to see CJMB full AI Analyst Report?
CJMB Stock Chart & Stats
$1.45
--
Market closed
$1.45
--
Day’s Range― - ―
52-Week Range$0.65 - $5.88
Previous CloseN/A
VolumeN/A
Average Volume (3M)10.79K
Market Cap
$4.33M
Enterprise Value$4.44M
Total Cash (Recent Filing)$1.42M
Total Debt (Recent Filing)$2.24M
Price to Earnings (P/E)―
Beta0.19
Next Earnings
Aug 13, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.09
Shares Outstanding5,646,118
10 Day Avg. Volume12,214
30 Day Avg. Volume10,793
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)2.09
Price to Sales (P/S)0.85
P/FCF Ratio-0.94
Enterprise Value/Market Cap1.03
Enterprise Value/Revenue0.83
Enterprise Value/Gross Profit2.31
Enterprise Value/Ebitda-0.45
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Leverage / Minimal DebtEssentially zero debt materially reduces fixed interest obligations and bankruptcy risk, improving runway relative to highly levered peers. This durable balance-sheet feature preserves flexibility to raise capital or restructure without immediate debt-service strain, aiding multi-month recovery plans.
Positive Gross Margins On Core ServicesStable mid-to-high 30% gross margins indicate the core freight/logistics services still cover direct costs, showing intact unit economics. If the company can reduce overhead and recapture volumes, operating leverage could restore profitability over several quarters, making margins a foundational recovery lever.
ATM Equity Program Adds Financing OptionalityAn at-the-market program creating up to $5M of incremental equity capacity provides a concrete, ongoing channel to shore up liquidity without large one-off financings. This structural access to capital helps manage negative cash flow and supports operational continuity while strategic fixes are implemented.
Bears Say
Severe And Persistent UnprofitabilityA TTM net margin near -185% signals losses vastly exceed revenues, eroding shareholder equity and limiting internal capacity to fund operations. Persistent deep unprofitability reflects structural issues in scale or cost control that will likely require multi-quarter operational overhaul or external capital to correct.
Negative And Worsening Cash GenerationWorsening free cash flow means operations consume cash rather than fund them, increasing dependence on financing or equity raises. Over several months this constrains investments, forces cost cuts, and raises dilution risk, making sustainable recovery and creditor confidence more difficult without corrective action.
Nasdaq Listing Compliance Risk (equity & Bid Notices)Deficiency notices on stockholders' equity and minimum bid price create structural listing risk that can lead to delisting, reduced liquidity, shareholder dilution via reverse splits or emergency financings, and higher capital costs. These outcomes materially impair long-term financing and investor access.
Callan JMB, Inc. News
CJMB FAQ
What was Callan JMB, Inc.’s price range in the past 12 months?
Callan JMB, Inc. lowest stock price was $0.65 and its highest was $5.88 in the past 12 months.
What is Callan JMB, Inc.’s market cap?
Callan JMB, Inc.’s market cap is $4.33M.
When is Callan JMB, Inc.’s upcoming earnings report date?
Callan JMB, Inc.’s upcoming earnings report date is Aug 13, 2026 which is in 32 days.
How were Callan JMB, Inc.’s earnings last quarter?
Currently, no data Available
Is Callan JMB, Inc. overvalued?
According to Wall Street analysts Callan JMB, Inc.’s price is currently Overvalued.
Does Callan JMB, Inc. pay dividends?
Callan JMB, Inc. does not currently pay dividends.
What is Callan JMB, Inc.’s EPS estimate?
Callan JMB, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Callan JMB, Inc. have?
Callan JMB, Inc. has 5,646,118 shares outstanding.
What happened to Callan JMB, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Callan JMB, Inc.?
Currently, no hedge funds are holding shares in CJMB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Callan JMB, Inc.
Callan JMB Inc., operating primarily through its subsidiary Coldchain Technology Services, LLC, specializes in providing temperature-controlled logistics solutions specifically for the life sciences sector. The company's services include comprehensive frozen shipping capabilities essential for a wide range of sensitive biological and medical materials. These critical shipments encompass items such as personalized medicines, cell-based therapies, stem cells, cell lines, vaccines, diagnostic samples, reproductive materials (including semen, eggs, and embryos), cord blood, organs, biopharmaceutical products, infectious substances, and other vital commodities. Additionally, Callan JMB Inc. offers packaging services for other perishable (non-pharmaceutical) client goods, alongside technical support. The company was founded in 2006 and is based in Spring Branch, Texas.
Technical Analysis
Singularity Future Technology
―
Addentax Group
―
PS International Group
―
Globavend Holdings Ltd.
―
New Century Logistics (BVI) Ltd.
―
Ownership Overview
56.52% Insiders
0.42% Mutual Funds
4.43% Other Institutional Investors
38.51% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---